Literature DB >> 16231318

Thyroid hormone receptor beta1 in normal colon and colorectal cancer-association with differentiation, polypoid growth type and K-ras mutations.

Tuomo T Hörkkö1, Karoliina Tuppurainen, Susannah M George, Petra Jernvall, Tuomo J Karttunen, Markus J Mäkinen.   

Abstract

The precursors for colorectal cancer include polypoid (conventional), flat and serrated adenomas. Polypoid growth in polypoid adenomas and serrated adenomas is associated with K-ras mutations. The regulation of polypoid or nonpolypoid growth is not well known, but could be related to trophic stimuli, such as thyroid hormones. Hence, we investigated the expression pattern of thyroid hormone receptor TRbeta1 in colorectal mucosa and in colorectal tumours and its relationship to tumour growth type. One hundred fourteen colorectal carcinoma specimens were evaluated for TRbeta1. Normal mucosa, adjacent adenomatous component (N = 46) and lymph node metastases (N = 28) were analysed when present, and the results were confirmed by Western blot analysis in selected cases. Nuclear TRbeta1 was almost always present in normal epithelium (96%), but less frequent in adenomas (83%) and in cancer (68%; p < 0.001 and p < 0.001, respectively). TRbeta1 was associated with polypoid growth, presence of K-ras mutations and also with a higher WHO histological grade and advanced Dukes' stage. Cytoplasmic expression of TRbeta1 was observed in nonneoplastic and neoplastic epithelium. In Western blot analysis, a 58 kDa band corresponding to TRbeta1 was expressed in normal mucosa and in colorectal cancer specimens with positive immunohistochemistry. Association of TRbeta1 expression with growth pattern and the presence of K-ras mutations suggest that abnormalities in thyroid hormone signalling involving TRbeta1 play a role in the development of some types of colorectal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16231318     DOI: 10.1002/ijc.21556

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  22 in total

1.  Integrated genomic profiling identifies microRNA-92a regulation of IQGAP2 in locally advanced rectal cancer.

Authors:  Raphael Pelossof; Oliver S Chow; Lauren Fairchild; J Joshua Smith; Manu Setty; Chin-Tung Chen; Zhenbin Chen; Fumiko Egawa; Karin Avila; Christina S Leslie; Julio Garcia-Aguilar
Journal:  Genes Chromosomes Cancer       Date:  2016-04       Impact factor: 5.006

Review 2.  Thyroid hormones and their nuclear receptors: new players in intestinal epithelium stem cell biology?

Authors:  Maria Sirakov; Elsa Kress; Julien Nadjar; Michelina Plateroti
Journal:  Cell Mol Life Sci       Date:  2014-03-07       Impact factor: 9.261

3.  Thyroid dysfunction, thyroid hormone replacement and colorectal cancer risk.

Authors:  Ben Boursi; Kevin Haynes; Ronac Mamtani; Yu-Xiao Yang
Journal:  J Natl Cancer Inst       Date:  2015-04-08       Impact factor: 13.506

Review 4.  Thyroid hormone regulation of adult intestinal stem cells: Implications on intestinal development and homeostasis.

Authors:  Guihong Sun; Julia Roediger; Yun-Bo Shi
Journal:  Rev Endocr Metab Disord       Date:  2016-12       Impact factor: 6.514

5.  A case of resistance to thyroid hormone with thyroid cancer.

Authors:  Hee Kyung Kim; Doi Kim; Eun Hyung Yoo; Ji In Lee; Hye Won Jang; Alice Hyun Kyung Tan; Kyu Yeon Hur; Jae Hyeon Kim; Kwang-Won Kim; Jae Hoon Chung; Sun Wook Kim
Journal:  J Korean Med Sci       Date:  2010-08-12       Impact factor: 2.153

6.  Incidentally discovered adrenal myelolipoma associated with hyperthyroidism.

Authors:  Hisamitsu Ide; Yuichi Terado; Takashi Nakagawa; Keisuke Saito; Yutaka Kamiyama; Satoru Muto; Hiroshi Okada; Tetsuo Imamura; Shigeo Horie
Journal:  Int J Clin Oncol       Date:  2007-10-22       Impact factor: 3.402

7.  Novel oncogenic actions of TRbeta mutants in tumorigenesis.

Authors:  Celine J Guigon; Sheue-yann Cheng
Journal:  IUBMB Life       Date:  2009-05       Impact factor: 3.885

Review 8.  Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.

Authors:  Changxue Lu; Sheue-Yann Cheng
Journal:  J Mol Endocrinol       Date:  2009-09-09       Impact factor: 5.098

Review 9.  Thyroid hormone actions in liver cancer.

Authors:  Sheng-Ming Wu; Wan-Li Cheng; Crystal D Lin; Kwang-Huei Lin
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

10.  Hypothyroidism enhances tumor invasiveness and metastasis development.

Authors:  Olaia Martínez-Iglesias; Susana García-Silva; Javier Regadera; Ana Aranda
Journal:  PLoS One       Date:  2009-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.